From: Avenanthramide supplementation attenuates exercise-induced inflammation in postmenopausal women
 | SOD | GPX | GSH | GSSG | GSH:GSSG | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
C | AVA | C | AVA | C | AVA | C | AVA | C | AVA | ||
Pre-Supplementation | Rest | 408 ± 20.6 | 410 ± 19.9 | 440 ± 18.9 | 452 ± 16.2 | 5.90 ± 0.19 | 5.90 ± 0.10 | 1.10 ± 0.09 | 1.10 ± 0.13 | 5.36 ± 0.20 | 5.36 ± 0.19 |
24 h Post-DW | 393 ± 34.6 | 436 ± 10.0 | 399 ± 19.7 | 445 ± 19.3 | 6.57 ± 0.19 | 6.26 ± 0.12 | 1.15 ± 0.08 | 1.20 ± 0.10* | 5.71 ± 0.21 | 5.20 ± 0.04 | |
48 h Post-DW | 383 ± 15.3 | 403 ± 20.3 | 406 ± 14.1 | 436 ± 50.2 | 6.44 ± 0.21 | 7.05 ± 0.12 | 1.07 ± 0.10 | 1.14 ± 0.13 | 6.03 ± 0.22* | 6.18 ± 0.17* | |
Post-Supplementation | Rest | 374 ± 38.7 | 419 ± 21.1 | 419 ± 14.1 | 319 ± 17.9¥ | 5.76 ± 0.17 | 6.46 ± 0.20 | 1.07 ± 0.07 | 1.16 ± 0.12 | 5.41 ± 0.15 | 5.59 ± 0.13 |
24 h Post-DW | 353 ± 23.6 | 362 ± 60.1 | 376 ± 11.9 | 312 ± 24.6¥ | 6.00 ± 0.15 | 6.65 ± 0.18 | 1.19 ± 0.05* | 1.19 ± 0.13 | 5.03 ± 0.17 | 5.57 ± 0.10 | |
48 h Post-DW | 389 ± 17.5 | 449 ± 6.5§ | 397 ± 11.9 | 336 ± 61.9 | 6.27 ± 0.08 | 6.48 ± 0.15 | 1.02 ± 0.07 | 1.10 ± 0.06 | 6.16 ± 0.16* | 5.89 ± 0.17 |